LOW-DOSE TOREMIFENE IN THE TREATMENT OF ESTROGEN-RECEPTOR-POSITIVE ADVANCED BREAST-CANCER IN POSTMENOPAUSAL WOMEN

被引：0
|
作者：
VALAVAARA, R [1 ]
PYRHONEN, S [1 ]
机构：
[1] UNIV HELSINKI, CENT HOSP, SF-00290 HELSINKI 29, FINLAND
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1989年 / 46卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：966 / 973
页数：8
相关论文
共 50 条
  • [31] INFLUENCE OF DIFFERENT COMBINATIONS OF TAMOXIFEN AND TOREMIFENE ON ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER CELL-LINES
    CORADINI, D
    BIFFI, A
    CAPPELLETTI, V
    DIFRONZO, G
    CANCER DETECTION AND PREVENTION, 1995, 19 (04): : 348 - 354
  • [32] Pharmacogenomic prediction of breast cancer treatment outcome with adjuvant tamoxifen in postmenopausal women with estrogen receptor-positive breast cancer
    Pribylova, O.
    Petruzelka, L. B.
    Argalaczova, S.
    Konopasek, B.
    Drazdakova, J.
    Slanar, O.
    Slanar, O.
    Zima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] PHASE-I CLINICAL AND PHARMACOKINETICS STUDY OF HIGH-DOSE TOREMIFENE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    BISHOP, J
    MURRAY, R
    WEBSTER, L
    PITT, P
    STOKES, K
    FENNESSY, A
    OLVER, I
    LEBER, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (03) : 174 - 178
  • [34] Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer
    Meghan R. Flanagan
    David R. Doody
    Jenna Voutsinas
    Qian Wu
    Kalyan Banda
    Nima Sharifi
    Christopher I. Li
    Vijayakrishna K. Gadi
    Annals of Surgical Oncology, 2022, 29 : 7194 - 7201
  • [35] Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow
    Johanna M. Buschhaus
    Brock A. Humphries
    Samantha S. Eckley
    Tanner H. Robison
    Alyssa C. Cutter
    Shrila Rajendran
    Henry R. Haley
    Avinash S. Bevoor
    Kathryn E. Luker
    Gary D. Luker
    Oncogene, 2020, 39 : 5649 - 5662
  • [36] HIGH-DOSE VERSUS LOW-DOSE CMFP REGIMEN IN ADVANCED BREAST-CANCER
    KUMAR, A
    KHANNA, NN
    PANT, GC
    KHANNA, S
    JOURNAL OF SURGICAL ONCOLOGY, 1984, 25 (04) : 300 - 302
  • [37] Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer
    Flanagan, Meghan R.
    Doody, David R.
    Voutsinas, Jenna
    Wu, Qian
    Banda, Kalyan
    Sharifi, Nima
    Li, Christopher I.
    Gadi, Vijayakrishna K.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (11) : 7194 - 7201
  • [38] AN ESTROGEN-RECEPTOR GENETIC-POLYMORPHISM AND A HISTORY OF SPONTANEOUS-ABORTION - CORRELATION IN WOMEN WITH ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER BUT NOT IN WOMEN WITH ESTROGEN-RECEPTOR NEGATIVE BREAST-CANCER OR IN WOMEN WITHOUT CANCER
    LEHRER, SP
    SCHMUTZLER, RK
    RABIN, JM
    SCHACHTER, BS
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (02) : 175 - 180
  • [39] Case 24-2005: A woman with estrogen-receptor-positive breast cancer
    Denes, AE
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21): : 2304 - 2304
  • [40] Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow
    Buschhaus, Johanna M.
    Humphries, Brock A.
    Eckley, Samantha S.
    Robison, Tanner H.
    Cutter, Alyssa C.
    Rajendran, Shrila
    Haley, Henry R.
    Bevoor, Avinash S.
    Luker, Kathryn E.
    Luker, Gary D.
    ONCOGENE, 2020, 39 (34) : 5649 - 5662
12345